Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
93.38
-3.72 (-3.83%)
At close: Oct 23, 2026, 4:00 PM EDT
92.07
-1.31 (-1.40%)
After-hours: Oct 23, 2026, 7:31 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.37 billion as of October 23, 2026. It is the 8,404th most valuable company in the world and the 2,024th biggest in the United States. Its market cap has increased by 201.01% in one year.
Market Cap
1.37B
Enterprise Value
1.42B
1-Year Change
201.01%
Global Rank
Country Rank
#2,024 United States
Category
ChartMarket Cap Chart
Since May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.37B, an increase of 593.28%. That is a compound annual growth rate of 123.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.37B | 19.62% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.49B |
| Nanobiotix | 1.48B |
| Ascentage Pharma Group International | 1.46B |
| AnaptysBio | 1.43B |
| Korsana Biosciences | 1.41B |
| Ocular Therapeutix | 1.41B |
| Tyra Biosciences | 1.40B |
| ORIC Pharmaceuticals | 1.38B |